Specific inhibitors of HES1, such as JI051 and its derivative JI130, were tested on pancreatic cancer cell lines and in xenograft experiments, showing suppression of cell growth and cell cycle arrest in vitro and a significant decrease in tumor growth in vivo [74]. This evidence concerns the gene HES1 and familial pancreatic carcinoma.